Friday, January 18, 2013

BDP Week Featured Sessions: Progress in Better Understanding of Viral Filtration

The virus filtration step is one of the most critical and expensive steps in the biopharmaceutical process. As such it is important to be aware of the emerging technologies and advanced techniques for filtration that are being used for filtration of viruses and other contaminants that can impact the quality of your product and process.

At Biopharmceutical Development and Production Week, these sessions will highlight some of the cutting-edge technologies in the area of viral filtration with a discussion of their performance, lessons learned to date and their impact on virus filtration capabilities.  Here are a few of the top sessions highlighting virus filtration:

High Titer and Highly Purified Virus Stocks Preparations in Virus Clearance Studies
Horst Ruppach, Ph.D., Global Manager of Viral Clearance and Global
Coordinator Virology, Charles River Biopharmaceutical Services, Germany

The Smart Way to Optimize Virus Filtration Steps
Anika Meyer, Product Manager, Viral Clearance,
Sartorius Stedim Biotech GmbH, Germany

Artifacts of Validation Not Represented at Manufacturing Scale
Paul Genest, Ph.D., Senior Consulting Engineer, EMD Millipore

Biopharmaceutical Development and Process Week will take place February 25-March 1, 2013 in Huntington Beach, California.  All sessions focusing on Viral Safety for Biologics will take place Monday, February 25 and Tuesday, February 26.  For more information about these sessions and the rest of the agenda, download the brochure here.  If you'd like to register to join us, mention code BDP13JP you'll save 20% off the standard rate!  If you have any questions about this event, feel free to reach out to email Jennifer Pereira.

Share this article with your social network, just click below to share now!

No comments :

Post a Comment